Defactinib hydrochloride is under clinical development by Verastem and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I drugs for Colorectal Cancer have a 75% phase ...

Even though the December quarter (Q3FY25) earnings of domestic IT majors TCS, Infosys, HCL Tech, and Wipro were mixed, they did not bring many disappointments. This has raised hopes that the worst ...

Analysts noted that despite delivering a solid financial performance led by a sharp uptick in deal wins, both TCS and HCL Tech faced pressure due to higher expectations on the Street. India's ...

HCL Technologies (HCLTech), one of India’s leading IT firms, reported a modest 7% average salary hike for its employees, while its CEO, C Vijayakumar, received a staggering 190% increase in ...

HCL Tech Q3 Results Live: IT services company HCL Technologies on Monday reported 6% growth in its consolidated net profit at Rs 4,591 crore for the quarter ended December 2024. The same stood at Rs 4 ...

HCL Tech declared a fourth interim dividend of ₹18 per share, including a ₹6 special dividend marking 25 years of public listing. Q3FY25 net profit rose 5.5% YoY to ₹4,591 crore, with revenue growth ...

HCL Technologies along with 13 other companies will be releasing its financial performance result for the quarter that ended on December 31, 2024 (Q3) for the financial year 2024-25 (FY25) on Monday.